These results identify within the ccRCC NF-κB signature several well-established mediators of the NF-κB pro-inflammatory and cell-survival responses, as well as an unanticipated subset of IFN regulators. This evidence concerns the gene NFKB1 and nonpapillary renal cell carcinoma.